SDGCF logo

Sundrug Co.,Ltd. (SDGCF) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

SDGCF representa a Sundrug Co.,Ltd., una empresa del sector Healthcare con un precio de $ (capitalización de mercado 0). Calificado con 48/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.

Ultimo analisis: 17 mar 2026
Puntuación de IA de 48/100

Sundrug Co.,Ltd. (SDGCF) Resumen de Asistencia Médica y Tuberías

CEOHiroshi Sadakata
Empleados6662
Sede CentralFuchu, JP
Año de la oferta pública inicial (OPI)2014

Sundrug Co., Ltd., a Japanese retailer, operates drug and discount stores offering pharmaceuticals, cosmetics, food, and household goods. With a market capitalization of $3.30 billion and a P/E ratio of 14.96, Sundrug distinguishes itself through a broad product portfolio and a widespread store network across Japan.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 17 mar 2026

Tesis de Inversión

Sundrug Co., Ltd. presents a stable investment profile, characterized by its established retail presence and diverse product offerings in the Japanese market. The company's P/E ratio of 14.96 suggests a reasonable valuation compared to its earnings, while a dividend yield of 3.26% offers an income component for investors. A low beta of 0.06 indicates that the stock is less volatile than the overall market. Growth catalysts include potential expansion of its store network and increased demand for healthcare and consumer products in Japan. However, investors may want to evaluate risks such as competition from other retailers and potential changes in consumer spending patterns. The company's profit margin of 3.7% and gross margin of 25.6% reflect its profitability and operational efficiency.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Market capitalization of $3.30 billion, reflecting its significant presence in the Japanese retail market.
  • P/E ratio of 14.96, indicating a potentially reasonable valuation compared to its earnings.
  • Dividend yield of 3.26%, offering an income component for investors.
  • Low beta of 0.06, suggesting lower volatility compared to the overall market.
  • Gross margin of 25.6%, reflecting its ability to manage production costs and pricing strategies.

Competidores y Pares

Fortalezas

  • Established brand and reputation in the Japanese market.
  • Diverse product offerings across drug stores and discount stores.
  • Widespread store network providing convenient access for customers.
  • Stable financial performance with consistent profitability.

Debilidades

  • Relatively low profit margin compared to some competitors.
  • Limited international presence.
  • Dependence on the Japanese market.
  • Potential vulnerability to changes in consumer spending patterns.

Catalizadores

  • Ongoing: Expansion of store network in Japan to increase market presence.
  • Ongoing: Enhancement of e-commerce platform to cater to online shoppers.
  • Upcoming: Potential development of new private label products to improve profitability.
  • Ongoing: Strategic alliances and partnerships to expand product offerings and reach.
  • Ongoing: Focus on healthcare services to cater to the aging population.

Riesgos

  • Ongoing: Intense competition from other retailers in the Japanese market.
  • Potential: Changes in government regulations affecting the healthcare and retail sectors.
  • Potential: Economic downturns impacting consumer spending.
  • Potential: Fluctuations in currency exchange rates affecting import costs.
  • Potential: Limited financial disclosure due to OTC listing.

Oportunidades de crecimiento

  • Expansion of Store Network: Sundrug can expand its market presence by opening new stores in underserved regions of Japan. The Japanese retail market is characterized by regional disparities, with some areas having a higher concentration of retail outlets than others. By strategically locating new stores in these underserved regions, Sundrug can tap into new customer bases and increase its overall market share. This expansion strategy could target both urban and rural areas, adapting the store format and product offerings to suit the specific needs of each location. The timeline for this expansion could be phased over the next 3-5 years, with a target of opening 10-15 new stores per year.
  • Enhancement of E-commerce Platform: Sundrug can enhance its e-commerce platform to cater to the growing demand for online shopping in Japan. The e-commerce market in Japan has been experiencing rapid growth, driven by increasing internet penetration and changing consumer behavior. By investing in its online platform, Sundrug can reach a wider customer base, offer greater convenience, and improve customer engagement. This enhancement could include features such as personalized recommendations, online ordering and delivery, and mobile app integration. The timeline for this enhancement could be implemented over the next 1-2 years, with a focus on improving user experience and expanding product offerings.
  • Development of Private Label Products: Sundrug can develop and expand its range of private label products to improve profitability and differentiate itself from competitors. Private label products typically offer higher profit margins compared to branded products, allowing retailers to improve their overall profitability. By developing its own line of private label products, Sundrug can also create a unique brand identity and build customer loyalty. These products could include pharmaceuticals, health and beauty items, and household goods. The timeline for this development could be phased over the next 2-3 years, with a focus on quality, value, and customer satisfaction.
  • Strategic Alliances and Partnerships: Sundrug can form strategic alliances and partnerships with other companies to expand its product offerings and reach new markets. These alliances could include partnerships with pharmaceutical companies, healthcare providers, and other retailers. By collaborating with other companies, Sundrug can leverage their expertise, resources, and distribution networks to enhance its competitive position and drive growth. For example, Sundrug could partner with a pharmaceutical company to develop and market new drugs, or with a healthcare provider to offer integrated healthcare services. The timeline for these alliances could be ongoing, with a focus on identifying mutually beneficial opportunities.
  • Focus on Healthcare Services: Sundrug can expand its focus on healthcare services by offering a wider range of services in its drug stores and pharmacies. The demand for healthcare services in Japan is increasing, driven by an aging population and growing awareness of health and wellness. By offering services such as health checkups, medication counseling, and disease management programs, Sundrug can attract new customers and build stronger relationships with existing customers. This expansion could also include the integration of technology, such as telemedicine and remote monitoring, to improve access to healthcare services. The timeline for this expansion could be phased over the next 3-5 years, with a focus on providing high-quality, patient-centered care.

Oportunidades

  • Expansion of e-commerce platform to reach a wider customer base.
  • Development of private label products to improve profitability.
  • Strategic alliances and partnerships to expand product offerings.
  • Focus on healthcare services to cater to the aging population.

Amenazas

  • Intense competition from other retailers in the Japanese market.
  • Potential changes in government regulations affecting the healthcare and retail sectors.
  • Economic downturns impacting consumer spending.
  • Fluctuations in currency exchange rates affecting import costs.

Ventajas competitivas

  • Established retail presence in Japan with a widespread store network.
  • Diverse product offerings catering to a wide range of consumer needs.
  • Strong brand recognition and customer loyalty.
  • Efficient supply chain and distribution network.

Acerca de SDGCF

Founded in 1957 and headquartered in Fuchu, Japan, Sundrug Co., Ltd. has evolved into a prominent operator of drug stores and discount stores throughout Japan. The company's business spans a diverse range of products, including pharmaceuticals, cosmetics, home appliances, clothing, car supplies, sports goods, alcoholic beverages, and fresh food. This extensive product offering allows Sundrug to cater to a wide customer base and meet various consumer needs. Sundrug's operations are divided into two primary segments: drug stores and discount stores. The drug stores focus on providing pharmaceutical products, health and beauty items, and over-the-counter medications, often including dispensing pharmacies. The discount stores offer a broader selection of products at competitive prices, attracting customers seeking value and convenience. With a workforce of 6662 employees, Sundrug maintains a significant retail presence across Japan. The company's strategy involves expanding its store network, enhancing its product offerings, and improving operational efficiency to drive growth and profitability. Sundrug's commitment to providing quality products and services has solidified its position in the Japanese retail market.

Qué hacen

  • Operates drug stores offering pharmaceuticals, health and beauty products, and over-the-counter medications.
  • Manages dispensing pharmacies providing prescription medications and pharmaceutical services.
  • Runs discount stores selling a wide range of products, including food, cosmetics, and household goods.
  • Offers home appliances, clothing, car supplies, and sports goods in its discount stores.
  • Sells alcoholic beverages and fresh food in select locations.
  • Provides kerosene and other seasonal products.

Modelo de Negocio

  • Generates revenue through the sale of pharmaceutical products and healthcare-related items in its drug stores.
  • Earns income from the sale of a diverse range of products in its discount stores.
  • Profits from dispensing prescription medications and providing pharmaceutical services in its pharmacies.
  • Utilizes a retail network of drug and discount stores to reach customers across Japan.

Contexto de la Industria

Sundrug Co., Ltd. operates within the competitive Japanese retail market, which includes drug stores, discount stores, and supermarkets. The healthcare and retail sectors in Japan are influenced by factors such as an aging population, increasing healthcare awareness, and evolving consumer preferences. The market is characterized by intense competition, with players like ANSLF, BUGDF, BUHPF, MAHLY, and MEPDF vying for market share. Sundrug differentiates itself through its diverse product offerings and widespread store network. The Japanese retail market is expected to grow steadily, driven by increasing consumer spending and demand for healthcare products and services.

Clientes Clave

  • Individuals seeking pharmaceutical products and healthcare-related items.
  • Consumers looking for a wide range of products at competitive prices.
  • Patients requiring prescription medications and pharmaceutical services.
  • Households purchasing everyday essentials and household goods.
Confianza de la IA: 69% Actualizado: 17 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Sundrug Co.,Ltd. (SDGCF): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para SDGCF.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para SDGCF.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para SDGCF.

MoonshotScore

48/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de SDGCF en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Hiroshi Sadakata

Unknown

Hiroshi Sadakata is the CEO of Sundrug Co., Ltd., leading a workforce of 6662 employees. Information regarding his detailed career history, educational background, and previous roles is not available in the provided data. As the CEO, he is responsible for overseeing the company's strategic direction, operational performance, and financial results. His leadership is crucial in navigating the competitive Japanese retail market and driving growth for Sundrug.

Historial: Due to limited information, specific achievements, strategic decisions, and company milestones under Hiroshi Sadakata's leadership cannot be detailed. His tenure and impact on the company's performance require further research and data.

Información del mercado OTC de SDGCF

The OTC Other tier, where Sundrug Co., Ltd. trades, represents the lowest tier of the OTC market. Companies in this tier often have limited or no financial disclosure, making it difficult for investors to assess their financial health and operational performance. Unlike companies listed on major exchanges like the NYSE or NASDAQ, OTC Other companies do not have to meet minimum listing standards, such as asset size, revenue, or profitability. This lack of regulatory oversight and transparency increases the risk for investors.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Liquidity for SDGCF on the OTC market is likely limited. OTC stocks generally have lower trading volumes and wider bid-ask spreads compared to exchange-listed stocks. This can make it difficult to buy or sell shares quickly and at a favorable price. Investors should be aware of the potential for price volatility and illiquidity when trading SDGCF on the OTC market.
Factores de riesgo OTC:
  • Limited financial disclosure increases the risk of investing in SDGCF.
  • Lower liquidity can make it difficult to buy or sell shares.
  • Lack of regulatory oversight increases the potential for fraud and manipulation.
  • Price volatility can lead to significant losses for investors.
  • OTC stocks are generally considered riskier than exchange-listed stocks.
Lista de verificación de diligencia debida:
  • Verify the company's registration and regulatory filings.
  • Review available financial statements and assess the company's financial health.
  • Research the company's management team and their track record.
  • Understand the company's business model and competitive landscape.
  • Assess the liquidity of the stock and the potential for price volatility.
  • Consider the risks associated with investing in OTC stocks.
  • Consult with a financial advisor before making any investment decisions.
Señales de legitimidad:
  • The company has been in operation since 1957, indicating a long history.
  • Sundrug has a significant number of employees (6662), suggesting a substantial operation.
  • The company operates a network of drug stores and discount stores across Japan.
  • Sundrug has a market capitalization of $3.30 billion, reflecting its size and value.
  • The company has a P/E ratio of 14.96 and a dividend yield of 3.26%, suggesting some financial stability.

Lo Que los Inversores Preguntan Sobre Sundrug Co.,Ltd. (SDGCF)

¿Cuáles son los factores clave para evaluar SDGCF?

Sundrug Co.,Ltd. (SDGCF) actualmente tiene una puntuación IA de 48/100, indicando puntuación baja. Fortaleza clave: Established brand and reputation in the Japanese market.. Riesgo principal a monitorear: Ongoing: Intense competition from other retailers in the Japanese market.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de SDGCF?

SDGCF actualmente puntúa 48/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de SDGCF?

Los precios de SDGCF se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre SDGCF?

La cobertura de analistas para SDGCF incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en SDGCF?

Las categorías de riesgo para SDGCF incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Intense competition from other retailers in the Japanese market.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de SDGCF?

La relación P/E para SDGCF compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está SDGCF sobrevalorada o infravalorada?

Determinar si Sundrug Co.,Ltd. (SDGCF) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de SDGCF?

Sundrug Co.,Ltd. (SDGCF) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Limited information available on CEO's background and track record.
  • OTC analysis based on general characteristics of the OTC market due to limited company-specific data.
Fuentes de datos

Popular Stocks